




13C Magnetic Resonance Spectroscopy Measurements
with Hyperpolarized [1-13C] Pyruvate Can Be Used to
Detect the Expression of Transgenic Pyruvate
Decarboxylase Activity In Vivo
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Purpose: Dissolution dynamic nuclear polarization can increase
the sensitivity of the 13C magnetic resonance spectroscopy
experiment by at least four orders of magnitude and offers a
novel approach to the development of MRI gene reporters
based on enzymes that metabolize 13C-labeled tracers. We
describe here a gene reporter based on the enzyme pyruvate
decarboxylase (EC 4.1.1.1), which catalyzes the decarboxyl-
ation of pyruvate to produce acetaldehyde and carbon dioxide.
Methods: Pyruvate decarboxylase from Zymomonas mobilis
(zmPDC) and a mutant that lacked enzyme activity were
expressed using an inducible promoter in human embryonic kid-
ney (HEK293T) cells. Enzyme activity was measured in the cells
and in xenografts derived from the cells using 13C MRS measure-
ments of the conversion of hyperpolarized [1-13C] pyruvate to
H13CO–3.
Results: Induction of zmPDC expression in the cells and in the
xenografts derived from them resulted in an approximately two-
fold increase in the H13CO–3/[1-
13C] pyruvate signal ratio follow-
ing intravenous injection of hyperpolarized [1-13C] pyruvate.
Conclusion: We have demonstrated the feasibility of using
zmPDC as an in vivo reporter gene for use with hyperpolarized 13C
MRS. Magn Reson Med 76:391–401, 2016. VC 2015 The
Authors. Magnetic Resonance in Medicine published by Wiley
Periodicals, Inc. on behalf of International Society for Mag-
netic Resonance in Medicine. This is an open access article
under the terms of the Creative CommonsAttribution License,
which permits use, distribution and reproduction in any
medium, provided the original work is properly cited.
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INTRODUCTION
Reporter genes provide a means of visualizing gene
expression in living organisms. The introduction of fluo-
rescence and bioluminescence reporter genes has revolu-
tionized molecular cell biology, to a large extent due to
the relative simplicity and speed of these imaging modal-
ities. However, despite good sensitivity, the use of these
techniques is restricted in vivo due to poor depth penetra-
tion, which limits their use in superficial tissues. Reporter
genes developed to work with positron emission tomogra-
phy have very good depth penetration and sensitivity but
have limited spatial resolution and may require an on-site
cyclotron for probe synthesis (1), whereas MR reporters
can have good spatiotemporal resolution and depth pene-
tration but may be limited by a lack of sensitivity. Several
systems have been developed that use T1 and T2 (*) MRI
contrast agents [reviewed in Lyons et al. (1) and Patrick
et al. (2)]. However, these can suffer from background sig-
nal, as water proton relaxation rates may change inde-
pendently of reporter gene expression, for example due to
hemorrhage, changes in vascularity, or the development
of air cavities and calcifications (3). Furthermore, phago-
cytosis by infiltrating macrophages of dead cells that con-
tain contrast agents can give rise to persistent nonspecific
contrast (3). In addition, high magnetic fields may be
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required to achieve sufficient contrast with some agents
that modulate T2/T2* relaxation rates (4).
The first enzyme-based magnetic resonance spectros-
copy (MRS) gene reporter was creatine kinase, which
was expressed in Escherichia coli (5), yeast (6), and
murine liver (7), where the activity of the enzyme was
detected by 31P MRS. This approach exploited the fact
that creatine kinase is not expressed endogenously in
these systems; however, the low sensitivity of 31P MRS
limited the temporal, and in the liver, spatial resolution.
There are several examples of 19F-based gene reporters,
where the reporter is an enzyme that catalyzes transforma-
tion of a fluorinated substrate. 19F MR-based reporters have
the advantage that there is effectively no background signal
in biological systems, the nucleus has a broad chemical shift
range and it is relatively sensitive to MRS detection. The
possibility of noninvasive monitoring of therapeutic gene
expression in vivo using 19F MRS was demonstrated in xen-
ografts stably expressing carboxypeptidase G2, a bacterial
enzyme that mediates the release of DNA alkylating agents
by enzymatic cleavage of labile pro-drugs (8). The conver-
sion of 3,5-difluorobenzoyl-L-glutamic acid to 3,5-difluoro-
benzoic acid was measured using 19F MRS and thus
provided a readout of the activity of this therapeutic trans-
gene within the target tissue (8). Another 19F MRS-based
reporter exploited the enzyme b-galactosidase, encoded by
the lacZ gene, which has been widely used as an optical
reporter. b-Galactosidase catalyzes the cleavage of 2-fluoro-
4-nitrophenyl b-D-galactopyranoside (OFPNPG) to aglycone
2-fluoro-4-nitrophenol, which results in the appearance of a
new resonance in the 19F spectrum (9). The expression of
lacZ in human PC-3 prostate carcinoma cells grown as xeno-
grafts in mice was detected by 19F MRS after intratumoral
injection of OFPNPG (9).
The introduction of dissolution dynamic nuclear
polarization, a method that can increase the sensitivity
of 13C MRS by at least four orders of magnitude, has
allowed imaging of some 13C labeled substrates and the
products of their metabolism in real time in vivo (10).
Reporter genes encoding enzymes that process hyperpo-
larized 13C-labeled tracers would give rise to signal,
which like 19F has no background and could be imaged
within a few minutes. The short half-life of the hyperpo-
larization and rapid clearance of small molecule metabo-
lites means that reporter gene expression could be
reinterrogated very rapidly. This is in contrast to report-
ers that use T1 or T2/T2* contrast agents, which may
require several hours or days to clear (2,11), which limits
the temporal resolution of longitudinal assessment of
gene expression using T1 or T2/T2*-weighted imaging.
The enzyme-based reporter genes that have been developed
for use with hyperpolarized 13C-labeled cell substrates are
summarized in Table 1. However, a number of factors have
prevented their successful implementation in vivo, including
insufficient levels of polarization, a short T1 relaxation time
of the hyperpolarized 13C label (12), low specific activity of
the enzyme with the labeled substrate (13), and insufficient
levels of enzyme activity in the expressing cells (12,14).
We demonstrate here the use of PDC, from the bacterium
Zymomonas mobilis, as an MR gene reporter in HEK293T
human embryonic kidney cells (15), and in implanted xeno-
grafts that were derived from these cells. The PDC-catalyzed
Table 1
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FIG. 1. (a) Reaction catalyzed by zmPDC and subsequent fate of
the carbon dioxide produced. CA, carbonic anhydrase. (b) Tet-on
PDC-GFP-V5/His vector map. BGH pA, bovine growth hormone
poly A sequence (ampicillin resistance cassette contained b-
lactamase coding sequence); ORI E. coli, bacterial origin of replica-
tion; pTRE3G, third generation trans-activator response element
containing incomplete herpes virus promoter; rtTA3, trans-activator
protein; UbqC, constitutive mammalian ubiquitin C promoter.
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decarboxylation of pyruvate to give acetaldehyde and car-
bon dioxide is a reaction that is not present in mammalian
tissues and can be monitored using 13C MRS measurements
of 13C bicarbonate production following injection of hyper-
polarized [1-13C] pyruvate (Fig. 1a). Labeled bicarbonate is
produced by spontaneous and carbonic anhydrase–cata-
lyzed exchange of the hyperpolarized 13C label between
13CO2 and the intracellular bicarbonate pool (16).
METHODS
All chemicals were purchased from Sigma Aldrich (Gil-
lingham, Dorset, UK), unless stated otherwise.
Generation of Clonal HEK293T Cells Stably Transfected
with Doxycycline-Inducible Vectors Expressing Wild-Type
and Mutant PDC
A DNA sequence encoding a monomer of pyruvate decar-
boxylase from Zymomonas mobilis (zmPDC) fused to a
green fluorescent protein (GFP) with V5 and histidine epi-
tope tags in a pEF6-V5/His vector (Life Technologies Ltd,
Paisley, UK) was cloned by PCR as an AgeI/FseI fragment
into a tet-on doxycycline-inducible vector (pBS-TRE3G-
YFP-ZnF-rtTA3pA) to give tet-on zmPDC-GFP-V5/His
(Fig. 1). A variant of this plasmid, encoding an inactive
H113Q point mutant of zmPDC (17), was made by cloning
a synthetic gene fragment into the tet-on zmPDC-GFP-V5/
His plasmid (see Supporting Information Section S1) to
give tet-on zmPDC/H113Q-GFP-V5/His. HEK293T cells
were grown at 37C in Dulbecco’s Modified Eagle’s
Medium (DMEM) (GIBCO Invitrogen, Carlsbad California,
USA) with 10% fetal bovine serum (PAA Laboratories
Ltd, Yeovil Somerset, UK), 4 mM glutamine (GIBCO Invi-
trogen) and 5% CO2. Plasmid DNA transfections were
performed with Lipofectamine (Life Technologies Ltd)
with a 10:1 molar ratio mixture of the tet-on PDC plasmid
and pPUR vector (Clontech Laboratories Inc., Mountain
View, California, USA). Stably transfected clones were
selected in media containing 2 mg/mL puromycin, picked,
and expanded (see Supporting Information Section S2).
Analysis of Cell Growth
Twenty-five thousand cells were seeded per well in 48-well
plates (NUNC; Thermo Fisher Scientific, Waltham, Massa-
chusetts, USA), with six replicates per experimental condi-
tion. Eight hours after seeding, an appropriate volume of a
1 mg/mL solution of doxycycline in sterile water, or water
alone, was added to the media. Confluence of the monolayer
was measured using an IncuCyte instrument (Essen Instru-
ments, Essen, Michigan, USA), which was then used to cal-
culate the cell doubling time using Prism 6.0 (GraphPad
Software, Inc., La Jolla, California, USA) .
Time Course of Doxycycline-Induced PDC Expression
The growth medium was refreshed 24 h after cell seed-
ing in T25 tissue culture flasks. For dose–response
experiments, doxycycline was added to the media at the
indicated concentrations, and the cells were harvested
48 h later. For time course experiments, the medium was
supplemented with 2 mg/mL of doxycycline at 24, 48, or
96 h before cell harvesting.
Cell Extraction and Western Blotting
Cells were lysed in passive lysis 5 buffer (Promega,
Madison, Wisconsin, USA), diluted in water, and con-
tained complete ethylenediaminetetraacetic acid–free pro-
tease inhibitor cocktail (Roche Applied Science, Basel,
Switzerland) as recommended by the manufacturer. Pro-
tein concentration was measured using a Bradford protein
assay and a Sunrise 96-well plate reader (Tecan Group
Ltd, M€annedorf, Switzerland). The protein was separated
by sodium dodecyl sulfate–polyacrylamide gel electropho-
resis, blotted onto a polyvinylidene difluoride membrane,
and probed for expression of the V5 epitope and a-actin
(see Supporting Information Section S3).
13C T1 Measurements In Vitro
Measurements were made using a 11.7 T Bruker Avance
IIþ 500 MHz spectrometer and an inversion recovery
pulse sequence in samples containing the molecule of
interest, 10% D2O and 4% bovine serum albumin with a
pH between 7.4 and 7.6. Table 2 shows the sample com-
position and the delays in the inversion recovery
sequence.
Dynamic Nuclear Polarization
[1-13C] or [2-13C] pyruvic acid were polarized and dis-
solved as described previously (18). The dissolved sam-
ples contained 75 mM [1-13C] or [2-13C] pyruvate (see
Supporting Information Section S4).
13C MRS Measurements with Hyperpolarized 13C-Labeled
Pyruvate In Vitro
Cells (5  107) in 2 mL of pyruvate-, and FBS-free
DMEM in a 10 mm NMR tube were placed in a vertical
bore 9.4T NMR spectrometer with a broadband probe
tuned to 13C (Varian NMR Instruments, Palo Alto, Cali-
fornia, USA). Typically 9-12 s after dissolution, 2 mL of
the dissolved polarized sample containing 75 mM 13C-
labeled pyruvate were injected into the tube, and 180
spectra with a flip angle of 12 were acquired (data
points¼ 5440, acquisition time¼0.170 s, repetition time
[TR]¼ 0.25 s, number of transients¼ 4, sweep width¼
16 kHz) at 37C.
1H MRS Measurements with [U-2H3] Pyruvate In Vitro
Sodium pyruvate was deuterated as described previously
(19). Approximately 5.0  107 cells were suspended in
pyruvate-free DMEM. Each cell suspension was split into
Table 2
Sample composition and the delays in the inversion recovery







[1-13C] pyruvate 10 220 16 0.5–200
[2-13C] pyruvate 10 220 16 0.5–200
13C bicarbonate 20 240 16 1.0–240
[1-13C]
acetaldehyde
5 55 16 0.1–40
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two equal volumes, one of which was pelleted and fro-
zen in liquid nitrogen. The remaining sample was resus-
pended in 0.54 mL of pyruvate-free DMEM (containing
5 mM 2,2,3,3-D4 sodium-3-trimethylsilylpropionate and
12.5% D2O) in a 5-mm-diameter NMR tube and placed
in a vertical bore 11.7 T Bruker Avance IIþ 500 MHz
spectrometer. Two or three control spectra were acquired
before 60 mL of a 0.25 M solution of sodium [U-2H3]
pyruvate in H2O was added to the cell suspension and
mixed. After the addition of 100 mL of mineral oil, the
sample was returned to the spectrometer and, after ther-
mal equilibration, a series of 16 1H spectra were col-
lected using a pulse and acquire sequence with 90 flip
angle pulses (data points¼16384, acquisition
time¼ 1.0 s, sweep width¼ 8 kHz, number of transi-
ents¼ 3, TR¼39 s). The cell pellets were lysed in
0.45 mL of ice-cold lysis buffer, essentially as described
above, except that the lysis buffer was diluted in
200 mM citrate buffer (pH 6.0). A 480-mL sample of the
lysate was then mixed with 60-mL of a solution of
10 mM thiamine pyrophosphate and 10 mM MgCl2 in
2H20 and used for
1H MRS measurements.
Animal Experiments
All animal experiments were performed in compliance
with a project license issued under the Animals (Scientific
Procedures) Act of 1986 and were designed with reference
to the UK Coordinating Committee on Cancer Research
guidelines for the welfare of animals in experimental neo-
plasia (20). Protocols were approved by the Cancer
Research UK, Cambridge Institute Animal Welfare and Eth-
ical Review Body. Six to eight week-old female severe com-
bined immune-deficient (SCID) mice (Charles River Ltd,
Margate, UK) were used in each experimental group.
Xenograft Implantation and Induction of PDC Expression
In Vivo
Each animal was injected subcutaneously in the left
flank with 0.1 mL of a cell suspension containing 2.5 
107 cells stably transfected with the tet-on PDC-GFP-V5/
His plasmid expressing the wild-type or mutant
enzymes. Xenograft diameters were measured using cali-
pers, and the length (L) and width (W) were used to cal-
culate their volumes (V) according to the formula V¼ 1=2
(LW2) (21).
The xenografts typically reached a volume of approxi-
mately 0.5–0.7 cm3 within 21–25 days from implanta-
tion. To induce PDC expression, a solution of 10 mg
mL1 doxycycline with 5% w/v sucrose was given to the
mice in their drinking water ad libitum for 96 h prior to
imaging experiments.
13C MRS Measurements In Vivo
Animals were anesthetized and monitored as described
previously (22). A 20-mm-diameter surface coil (Rapid
Biomedical GmbH, Rimpar, Germany) was placed over
the xenograft, and the entire assembly was placed in a
13C/1 H volume coil (Rapid Biomedical) in a 7T horizon-
tal bore magnet (Varian). Xenografts were localized in
transverse 1H images acquired using a spin-echo pulse
sequence (TR¼1.5 s; echo time¼ 10 ms; field of view¼
40 40 mm; data matrix¼128128; slice thickness¼
2 mm; number of slices¼15). Immediately after dissolu-
tion, 10 mL/g body weight of the hyperpolarized pyruvate
solution (typically 240 mL in total) was injected via the
tail vein over a period of 2 s. Spectroscopic acquisitions
were started 30 s from the injection. Single transient
spectra (128 spectra with TR¼ 500 ms, nominal flip
angle¼ 20, sweep width¼6 kHz; the delay from the
middle of the excitation pulse to the beginning of data
acquisition was 900 ms) from an 8-mm slice through the
tumor were acquired. The center frequencies for the
spectra were selected to be 175 ppm and 200 ppm for
experiments with [1-13C] pyruvate and [2-13C] pyruvate,
respectively. For experiments with [2-13C] pyruvate, the
protons were decoupled using a WALTZ decoupling
sequence during acquisition (B1 1.65 kHz), centered at
9.7 ppm.
Tissue Extraction
Freeze-clamped xenograft tissues were homogenized
using a manual Potter S homogenizer (Sartorius, Epsom,
UK) in 4 volumes (milliliters per gram wet weight of tis-
sue) of ice-cold lysis buffer. Homogenates were centri-
fuged at 16,200 g and 4C in an Eppendorf 5415D bench
top centrifuge (Eppendorf, Hamburg, Germany) to
remove debris.
Immunohistochemistry
Immunohistochemical protocols and image analysis were
performed using instruments, reagents, and software
from Leica (Leica Microsystems, Milton Keynes, UK)
unless stated otherwise. Xenografts were excised and
fixed in 4% neutral buffered formalin solution for 24 h
and then transferred to 70% ethanol. After paraffin
embedding, tissue sections were taken from the center of
the xenograft and stained for cleaved caspase 3 (CC3),
V5 epitope, and GFP expression. Hematoxylin and eosin
(H&E) staining was performed to assess tissue viability
(see Supporting Information Section S5).
Image Analysis
Slides were digitized using a Leica Aperio XT120 and
analyzed using Aperio ImageScope software. For analysis
of H&E staining, the area covered by nonviable xenograft
tissue (as judged by the loss of structural coherence and
visible chromatin condensation) was identified manually
and compared with the total xenograft area, and the
result was converted to percentage cell death. The
Aperio ImageScope Positive PixelCount v9 macro, tuned
to identify negatively and positively 3,3’-diaminobenzi-
dine–stained tissue, was used for quantification of CC3
staining, which is reported as the number of positive
pixels as a percentage of the total number of pixels.
Statistical Analysis
The results are presented as the mean6 standard devia-
tion unless stated otherwise. Statistical significance was
assessed using Microsoft Excel with a two-tailed t test at
the 95% confidence level.
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RESULTS
13C T1s measured in vitro were 42.2 s for [1-
13C] pyru-
vate (n¼ 2; 42.4 s and 42.0 s), 29.5 s for [2-13C] pyruvate
(n¼ 2; 29.4 s and 29.5 s), 11.5 s for [1-13C] acetaldehyde
(n¼ 2; 11.2 and 11.7 s), and 40.7 s for bicarbonate (n¼2;
40.7 s and 40.6 s) at 11.7T (Table 2). Although these T1
values were measured at 11.7T, we expect them to be
shorter (because of the effect of chemical shift anisot-
ropy) than those measured at 9.4 T and 7 T, which were
the magnetic field strengths used for the cell and xeno-
graft experiments, respectively.
Expression of PDC in HEK293T cells transfected with
the zmPDC-GFP-V5/His transgene was detectable on
western blots by 24 h after addition of 2 mg/mL of doxy-
cycline to the growth medium and showed further
increases at 48 and 96 h. Expression was dose depend-
ent, showing an increase between 0.5 and 2.0 mg/mL
doxycycline and was undetectable in the absence of the
drug (Fig. 2a). The H113Q mutant, which had no detect-
able PDC activity [data not shown and Huang et al. (17)],
showed greater doxycycline-induced expression than the
wild-type enzyme (Fig. 2b).
The cell doubling times of wild-type HEK293T cells,
cells transfected with zmPDC-GFP-V5/His, and cells
transfected with zmPDC/H113Q-GFP-V5/His increased
after the addition of doxycycline to the growth medium
in a dose-dependent manner. At 4 mg/mL doxycycline,
the doubling times of cells expressing the wild-type and
mutant enzymes were 129.46 7.6% and 146.86 35.6%,
respectively, of their doubling times in the absence of
doxycycline (Fig. 2c).
PDC activity in cells that had been transfected with
zmPDC-GFP-V5/His and grown in the presence of 2 mg/
mL doxycycline for 48 h was first assessed using 1H
MRS measurements of [2,2,2-2H3] acetaldehyde produc-
tion following the addition of [U-2H3] pyruvate (Fig. 3a).
Lysed cells showed a 5.4-fold higher acetaldehyde pro-
duction rate compared with intact cells (5.6  1046 0.8
 104 U/107 cells and 1.1  1046 0.2  104 U/107
cells [SD, n¼3], respectively), demonstrating that the
activity of the enzyme in the cells was limited by the
rate of pyruvate transport. PDC activity was not detecta-
ble in cells that did not express zmPDC-GFP-V5/His pro-
tein or that expressed zmPDC H113Q-GFP-V5/His
protein at 48 h after addition of 2 mg/mL doxycycline to
the growth medium [data not shown and Huang et al.
(17)]. We were unable to detect PDC activity in vivo in
xenografts derived from cells expressing zmPDC-GFP-
V5/His, using similar 1H MRS measurements, following
intraperitoneal injection of [U-2H3] pyruvate (see Sup-
porting Fig. S1). Addition of hyperpolarized [1-13C]
pyruvate to cells resulted in a time-dependent increase
in the bicarbonate signal at 162.8 ppm, which could be
followed using dynamic 13C MRS measurements (Fig.
3b). Doxycycline-induced expression of the wild-type
enzyme resulted in an approximately 2.5-fold higher 13C
bicarbonate/pyruvate signal ratio calculated from the
sum of first 80 spectra acquired after the addition of
75 mM hyperpolarized [1-13C] pyruvate (Fig. 3c, 3d),
when compared with uninduced cells or wild-type cells
incubated in the presence or absence of doxycycline.
Subcutaneous implantation of cells in SCID mice
resulted in xenografts that consisted predominantly of
HEK-293T cells (Fig. 4a). Xenografts derived from cells
transfected with the zmPDC-GFP-V5/His vector
expressed zmPDC-GFP-V5/His protein at 96 h after doxy-
cycline administration, as demonstrated by western blots
of tissue extracts. The protein was not detectable in the
absence of doxycycline administration or in xenografts
derived from wild-type HEK293T cells (Fig. 4b). zmPDC-
GFP-V5/His protein expression was confirmed by stain-
ing of tissue sections with antibodies against GFP and
the V5 epitope (Fig. 4c). Expression was also confirmed
by imaging GFP fluorescence at 48 and 96 h after doxy-
cycline administration (Fig. 4d).
FIG. 2. (a) Induction of PDC-GFP-V5/His protein expression in
vitro. Western blot of a protein extract prepared from cells trans-
fected with the tet-on PDC-GFP-V5/His construct, grown with the
indicated concentrations of doxycycline for the indicated times (h)
and harvested when 80% confluent. A total of 20 mg of protein
was loaded per well. Membranes were probed with antibodies
against the V5 tag and actin (loading control). The typical expo-
sure time of the x-ray film was 10–15 s. (b) Western blot of a pro-
tein extract prepared from cells transfected with the tet-on PDC-
GFP-V5/His and tet-on PDC/H113Q-GFP-V5/His constructs and
harvested 48 h after the addition of 2 mg/mL doxycycline to the
growth medium. (c) Effect of doxycycline-induced PDC-GFP-V5/
His and PDC/H113Q -GFP-V5/His expression on cell doubling
times. Four different clones stably transfected with the tet-on
PDC-GFP-V5/His construct and four clones transfected with the
tet-on PDC/H113Q -GFP-V5/His construct were used. Untrans-
fected HEK93T cells were used as controls. The data for each
clone are an average of at least two independent experiments,
each of which was seeded in six replicates. Error bars represent
one standard deviation of the mean. Only positive or negative
error bars are shown for clarity.
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There was some evidence of a decrease in the growth
rate of xenografts expressing the wild-type (zmPDC-GFP-
V5/His) and mutant enzymes (zmPDC/H113Q-GFP-V5/
His) following doxycycline administration; however, this
decrease was not statistically significant (Fig. 5a and 5b,
respectively). The area of the tissue sections that com-
prised nonviable (necrotic and apoptotic) cells, as
assessed by H&E staining, did not differ significantly
between doxycycline-treated and untreated xenografts
(23.066.6% and 21.56 4.6%, respectively; SD, n¼ 4;
P¼ 0.79), nor did the levels of apoptosis, as assessed by
the levels of cleaved caspase 3 staining (14.365.6% and
15.56 8.4%, respectively; SD, n¼ 3; P¼ 0.85) (Fig. 4c).
Xenografts derived from cells transfected with zmPDC-
GFP-V5/His, in which expression of the enzyme had
been induced for 96 h by administration of doxycycline
in the drinking water, showed approximately two-fold
higher bicarbonate/pyruvate signal ratios, calculated
from the sum of the first 32 spectra acquired following
intravenous injection of hyperpolarized [1-13C] pyruvate,
when compared with the uninduced controls (2.9 
10261.1  102 [6SD], n¼7 and 1.5  1026 1.0 
102 [6SD], n¼10, respectively; P¼ 0.016) (Fig. 6a).
This increase was also observed when the bicarbonate
signal was expressed relative to the lactate signal (1.3 
10260.4  102 [6SD], n¼7 and 0.6  1026 0.5 
102 [6SD], n¼10; P¼ 0.008) or the total observable 13C
signal (7.0  1036 2.0  103 [6SD], n¼ 7 and 4.0 
10362.0  103 [6SD], n¼ 10; P¼ 0.008). The total
observable 13C signal included contributions from
FIG. 3. Detection of zmPDC activity in vitro following administration of [U-2H3] pyruvate and hyperpolarized [1-
13C] pyruvate. (a) 1H
spectra were acquired every 2 min, starting from 5 min after the addition of 25 mM [U-2H3] pyruvate, to a lysate prepared from 2.5 
107 cells that had been grown with 2 mg/mL doxycycline in the medium for 48 h prior to harvest. (b) Spectra acquired during the first
80 s after addition of 75 mM hyperpolarized [1-13C] pyruvate to suspensions of 5  107 cells that had been transfected with the tet-on
PDC-GFP-V5/His construct. The cells had been grown with 2 mg/mL doxycycline in the medium for 48 h prior to experiments (doxycy-
cline-treated tet-on PDC) or without doxycycline (untreated tet-on PDC). Peak assignments: lactate (185 ppm), pyruvate hydrate (181
ppm), alanine (177 ppm), pyruvate (172.9 ppm), bicarbonate (162.8 ppm). The insets show a 15 vertical expansion of the 161–168
ppm region of the spectra. The 13C bicarbonate peak at 162.8 ppm was accompanied by unidentified resonances at 166 ppm and
164.3 ppm. (c) Pyruvate and bicarbonate signal intensities following the addition of 75 mM hyperpolarized [1-13C] pyruvate to a suspen-
sion of cells expressing zmPDC. Measurements were made at 9.4T at 37 C (pH 7.0). The bicarbonate signal was multiplied 2000
times. (d) Average ratio of the bicarbonate to pyruvate signal intensities in panel b (n¼3 for all experimental conditions).
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pyruvate, pyruvate hydrate, alanine, lactate, and bicar-
bonate. There was no measurable increase in the bicar-
bonate signal in xenografts expressing the inactive
variant of zmPDC (tet-on zmPDC/H113Q-GFP-V5/His)
following doxycycline-induction of enzyme expression.
The bicarbonate/pyruvate signal ratio in untreated xeno-
grafts was 3.1  1026 3.1  102 (6SD, n¼ 3) and 2.3
 102 (0.6  102 and 3.9  102, n¼ 2) after 96 h of
FIG. 4. Demonstration of zmPDC pro-
tein expression in vivo in xenografts
derived from HEK293T cells transfected
with the tet-on PDC-GFP-V5/His con-
struct. (a) Fluorescence in situ hybrid-
ization of paraffin-embedded sections
of HEK-293T–derived xenografts. Rep-
resentative images of sections, stained
simultaneously with mouse-specific
centromeric probes (green) and human-
specific centromeric probes (red), were
acquired at 40 magnification. Nuclei
were stained with DAPI (blue). Scale
bar¼150 mm. (b) Western blot of pro-
tein extracts prepared from xenografts
derived from HEK293T cells transfected
with the tet-on PDC-GFP-V5/His con-
struct. Animals were given either no
doxycycline (–) or 10 mg/mL doxycy-
cline in their drinking water for 96 h
prior to preparation of the protein
extract (þ). (c) Representative formalin-
fixed stained sections taken from xeno-
grafts grown for  21–24 d following
subcutaneous implantation of cells
transfected with the tet-on PDC-GFP-
V5/His construct. Where indicated, the
mice were given 10 mg/mL doxycycline
solution in their drinking water for 96 h
prior to xenograft excision. PDC
expression was investigated by probing
the sections with anti-GFP and anti-V5
antibodies. Scale bars¼150 mm. (d)
GFP fluorescence overlaid on bright
field images acquired from a single
cohort of mice at 48 and 96 h after the
beginning of doxycycline administra-
tion. Ten mg/mL of doxycycline was
given in the drinking water where indi-
cated. Images were acquired with an
IVIS 200 camera and were analyzed
with Living Image software (both from
Perkin-Elmer). The post-doxycycline
GFP fluorescence images are represen-
tative of experiments on five animals.
The tumors were located on the backs
of the animals immediately above the
tail (see Supporting Information Section
S6).
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doxycycline treatment. There was also no change when
the bicarbonate signal was expressed relative to the total
observable 13C signal, which was 6.0  10363.0 
103 [6SD], n¼ 3) prior to treatment and 6.0  103 (2.0
 103 and 10.0  103, n¼2) after 96 h of doxycycline
treatment.
Because in many tissues there will be a background
bicarbonate signal, we also investigated whether PDC
activity could be assessed from the production of [1-13C]
acetaldehyde from [2-13C] pyruvate. However, a [1-13C]
acetaldehyde resonance was not detectable in experi-
ments using hyperpolarized [2-13C] pyruvate in suspen-
sions of PDC-expressing cells (data not shown). In
experiments on xenografts derived from these cells, a
resonance at 209.4 ppm, corresponding to the resonance
frequency of [1-13C] acetaldehyde, was observed in some
summed 1H -decoupled 13C spectra 96 h after doxycy-
cline administration (five out of 10 experiments) (Fig.
6b). However, this resonance was also occasionally
detected in uninduced tissue (two out of 10 experi-
ments), indicating that the resonance was not specific to
PDC activity. A resonance at 205.6 ppm, tentatively
assigned to [1-13C] acetyl-coenzyme A (AcCoA) (23), was
also detectable in some summed 1H -decoupled spectra
acquired from xenografts, both before and after doxycy-
cline administration (Fig. 6b). In those animals that
showed this peak, its intensity, normalized to that of
[2-13C] pyruvate, increased approximately 1.9-fold
(1.96 0.6; SD, P< 0.01) at 96 h after doxycycline
administration.
DISCUSSION
We have demonstrated that the pyruvate decarboxylase
activity expressed by the zmPDC-GFP-V5/His fusion pro-
tein can be detected in vivo using hyperpolarized [1-13C]
pyruvate and 13C MRS and therefore that this system has
the potential to be used as an MR gene reporter. The size
FIG. 5. (a, b) Effect of induction of expression of wild-type (a) and mutant PDC (b) on xenograft growth. The size of the xenografts
derived from cells transfected with the tet-on PDC or tet-on H113Q constructs are expressed as the percentage of the volume meas-
ured at the beginning of doxycycline treatment (0 h). Caliper measurements of two xenograft diameters were made every 48 h from 21
d after implantation, when doxycycline was added to the drinking water as indicated. Euhus’ formula was used to calculate xenograft
volume as described in the Methods section. Error bars represent one standard deviation of the mean. Only positive or negative error
bars are shown for clarity. (c) Representative formalin-fixed sections taken from xenografts grown for 21–24 d following subcutaneous
implantation of cells transfected with the tet-on PDC-GFP-V5/His construct. Where indicated, the mice were given 10 mg/mL doxycy-
cline solution in their drinking water for 96 h prior to xenograft excision. The area of necrotic tissue was assessed via H&E staining, and
apoptosis was investigated by probing with an anti-CC3 antibody. Scale bars¼150 mm.
398 Dzien et al.
of the zmPDC coding sequence (1.60 kbp), although con-
siderably larger than that of GFP (0.73 kbp) and similar
fluorescent reporter genes, is comparable to that of the
widely used bioluminescence reporter, Firefly luciferase
(1.65 kbp). A compact reporter size is an advantage
when the payload constraints of delivery vectors are con-
sidered. Because it is a spectroscopic method in princi-
ple, it could be used with multiple gene reporters; for
example, we have shown recently that the urea trans-
porter can be used as a gene reporter in conjunction
with hyperpolarized [13C]urea (24). The 13C resonances
of urea, [1-13C] pyruvate, and bicarbonate are resolved,
therefore both reporters could be used in the same sys-
tem. This is in general not possible with MRI methods
that employ contrast agents modulating T1 or T2/T2*
relaxation times, nor for positron emission tomography–
based reporter genes (1), although there is this potential
with chemical exchange saturation transfer (CEST)-based
MRI gene reporters (25).
Doxycycline-induced expression of the zmPDC-GFP-
V5/His fusion protein caused a decrease in cell growth
rate in vitro (Fig. 2c). There was also some evidence for
a decrease in growth rate in vivo of the xenografts
derived from these cells following doxycycline adminis-
tration in the drinking water (Fig. 5a, 5b). These effects
on cell growth may be partially explained by the effects
of doxycycline itself. Doxycycline, among other tetracy-
clines, is a potent inhibitor of mitochondrial translation,
which inhibits formation of complexes I, III, IV, and V of
the mitochondrial electron transfer chain (26–29), lead-
ing to a decrease in citric acid cycle activity and, conse-
quently, de novo pyrimidine synthesis (26). Consistent
with this, we observed a decrease in the growth rate of
untransfected wild-type HEK293T cells in vitro after the
addition of doxycycline to the growth medium (Fig. 2c).
This growth inhibition was more pronounced, however,
in cells expressing the zmPDC-GFP-V5/His transgene
when compared with wild-type cells (Fig. 2c), suggesting
that growth could also be inhibited by expression of PDC
activity. However, the observation that expression of the
inactive (H113Q) mutant of the enzyme (17) also inhib-
ited cell growth (Fig. 2c) suggests instead that this is a
nonspecific effect of high-level protein expression rather
than expression of PDC activity per se. Moreover, this
may be due to the GFP component of the construct since
this has, in some contexts, been shown to have a nonspe-
cific toxic effect on expressing cells (30,31). The absence
of a significant increase in apoptosis and necrosis in the
cell line–derived xenografts in vivo, as assessed by anti-
CC3 and H&E staining, respectively (Fig. 6c), indicates
that zmPDC-GFP-V5/His expression has a cytostatic
rather than a cytotoxic effect. Therefore, the reporter
might be more appropriate for use in tissues with low
cell turnover.
Cell lysis increased the rate of [2,2,2-2H3] acetaldehyde
production from [U-2H3] pyruvate approximately five-
fold in cells expressing zmPDC, implying that detection
of PDC activity from measurements of labeled bicarbon-
ate production in vivo is limited by the rate of pyruvate
entry into the cell. This suggests that the reporter would
work better in cells with higher rates of pyruvate trans-
port and that there would be little to be gained from
increasing the expression level or specific activity of
zmPDC (eg, by removing the GFP tag), at least in
HEK293T cells.
FIG. 6. 13C MRS detection of zmPDC activity in vivo following
administration of hyperpolarized [1-13C] pyruvate. (a) 13C spectra
acquired from 8-mm-thick slices of xenografts 21 d after subcu-
taneous implantation HEK293T cells transfected with the PDC-
GFP-V5/His construct. Experiments were performed either without
doxycycline treatment (no doxycycline) or after 96 h of 10 mg/mL
doxycycline solution administration (96 hours post doxycycline). A
total of 10 mL/g body weight of a 75-mM solution of hyperpolar-
ized [1-13C] pyruvate was injected over 2 s. A total of 128 single
transient 13C spectra were acquired, starting 30 s from the injec-
tion (TR¼500 ms, nominal flip angle¼20, SW¼6 kHz; delay
from the middle of the excitation pulse to beginning of data acqui-
sition was 900 ms). The insets show a 10 vertical scale expan-
sion of the 162–168 ppm region of the resulting 13C spectra. Peak
assignments: lactate (185 ppm), pyruvate hydrate (181 ppm), ala-
nine (177 ppm), pyruvate (172.9 ppm), and bicarbonate (162.8
ppm). (b) Representative 1H-decoupled spectra acquired from
xenografts following injection of 10 mL/g body weight of 75 mM
hyperpolarized [2-13C] pyruvate. Spectra were acquired as
described in panel a. Peak assignments: [2-13C] pyruvate (207.4
ppm); the resonance at 205.6 ppm was tentatively assigned to
[1-13C] AcCoA.
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The background hyperpolarized 13C bicarbonate signal
observed in the experiments described here can be
explained by the activity of mitochondrial pyruvate
dehydrogenase (PDH), which was shown previously in
the rat heart to lead to the production of labeled bicar-
bonate from hyperpolarized [1-13C] pyruvate (32). An
alternative pathway involving pyruvate carboxylase has
been reported in isolated perfused mouse liver (33); how-
ever, HEK293T cells do not express this enzyme activity
(34). The background bicarbonate signal is expected to
be much less in tumor cells; for example, EL4 lymphoma
tumors show no detectable hyperpolarized bicarbonate
signal following injection of [1-13C] pyruvate (18).
The tet-on doxycycline-inducible gene expression sys-
tem used here allowed rapid and reversible gene expres-
sion by oral administration of doxycycline (35,36),
allowing each xenograft to be used as its own control,
which was important in demonstrating a PDC-dependent
increase in labeled bicarbonate production above the
background level of labeled bicarbonate. In principle, the
increased bicarbonate production in these experiments
could also have been due to an effect of doxycycline on
the production of CO2 by mitochondrial PDH activity.
However, this is unlikely, because doxycycline had no
effect on CO2 production in wild-type cells, where the
bicarbonate/pyruvate signal ratio was unaffected by dox-
ycycline addition and was similar to the ratio observed
in untreated cells transfected with the inducible wild-
type PDC vector (Fig. 3d). Moreover, doxycycline, by
inhibiting the mitochondrial respiratory chain, would
likely cause an increase in the mitochondrial NADH/
NADþ ratio by decreasing the rate of NADH oxidation
(37). An increase in mitochondrial NADH/NADþ ratio
would be expected to inhibit PDH (38,39), leading to a
decrease in CO2 and bicarbonate production rather than
an increase. In a limited number of experiments with
xenografts expressing the mutant enzyme, we were
unable to demonstrate an increase in bicarbonate produc-
tion following administration of doxycycline in the
drinking water.
An alternative approach to circumvent the problem of
background bicarbonate signal would be to use hyperpo-
larized [2-13C] pyruvate and detect the signal from
[1-13C] acetaldehyde. However, we were unable to repro-
ducibly detect [1-13C] acetaldehyde, which may be
explained by the short T1 of [1-
13C] acetaldehyde
(approximately 11.0 s compared with 40.7 s in bicarbon-
ate) as well as its close proximity to the much larger
pyruvate signal. In addition, rapid metabolic conversion
of [1-13C] acetaldehyde to [1-13C] acetate, and further to
[1-13C] AcCoA and [1-13C] acetyl-carnitine, has been
observed previously in experiments with hyperpolarized
[1-13C] acetate in vivo (23,40), which will decrease the
steady state pool size of labeled acetaldehyde. Measure-
ments of 13C label flux between hyperpolarized [1-13C,
U-2H5] ethanol and [1-
13C] acetate in mouse liver showed
no evidence of the [1-13C, U-2H4] acetaldehyde interme-
diate, despite the much longer T1 of the deuterated acet-
aldehyde, which was approximately 19 s. Again this was
attributed to a low steady-state concentration of the
labeled intermediate (22). Because [1-13C] acetaldehyde
exists in equilibrium with the hydrated form, with the
hydrate 13C resonance at 91.4 ppm (data not shown), this
will further decrease the sensitivity of its detection by
13C MRS (41). The resonance detected in xenografts at
205.6 ppm with hyperpolarized [2-13C] pyruvate is likely
to be from [1-13C] AcCoA produced by PDH activity, as
has been observed previously in heart muscle following
administration of hyperpolarized [2-13C] pyruvate (42).
However, this would not explain the increase in this sig-
nal observed following doxycycline administration in
the experiments described here. A possible explanation
for this is that there is an increase in [1-13C] acetate for-
mation resulting from aldehyde dehydrogenase 2–cata-
lyzed oxidation of the [1-13C] acetaldehyde produced by
PDC and that this is then rapidly converted to AcCoA by
thiokinase. Build-up of AcCoA has been observed in
alcoholic fatty liver disease, where acetate produced by
mitochondrial aldehyde dehydrogenase 2 from ethanol-
derived acetaldehyde is converted to AcCoA, but its fur-
ther metabolism via the citric acid cycle is limited due
to product inhibition of isocitrate dehydrogenase and a-
ketoglutarate dehydrogenase by NADH produced during
acetaldehyde oxidation (43).
In conclusion, we have demonstrated the feasibility of
using zmPDC as an MR gene reporter when used with
hyperpolarized [1-13C] pyruvate. However, the levels of
bicarbonate produced above background were low,
which would make it challenging to use in conjunction
with an imaging experiment. Increasing zmPDC expres-
sion, at least in the cells used here, is unlikely to
improve the sensitivity of the reporter, because PDC
activity appeared to be limited by pyruvate transport
into the cell. However, the potential for increased tempo-
ral resolution resulting from rapid signal acquisition
coupled with subsequent rapid decay of the hyperpolar-
ized signals and the capability of this reporter to be com-
bined with other spectroscopy-based gene reporters in
the same experiment merits further development of this
and other enzyme-based gene reporters for use with
hyperpolarized 13C MRS.
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Supporting Figure S1. 1H STEAM spectrum acquired from a 1 cm3 voxel
within the xenograft after intraperitoneal administration of [U-2H3] pyruvate.
The animals were given 10 mg/mL doxycycline in their drinking water for
72 h prior to the experiments. The inset shows an expansion of the 10–8
ppm region of the spectrum with the vertical scale expanded by 10. The
spectrum is representative of two independent experiments. The assign-
ments were made by comparison with published spectra (Gillies RJ, Morse
DL. In vivo magnetic resonance spectroscopy in cancer. Ann Rev Biomed
Bioeng 2005;7:287–326).
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